The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Published version of a preprint
Abstract
Purpose: Myeloid-derived suppressor cells (MDSC) are considered an important T-cell immunosuppressive component in cancer-bearing hosts. The factors that attract these cells to the tumor microenvironment are poorly understood. IL8 (CXCL8) is a potent chemotactic factor for neutrophils and monocytes. Experimental Design: MDSC were characterized and sorted by multicolor flow cytometry on ficoll-gradient isolated blood leucokytes from healthy volunteers (n = 10) and advanced cancer patients (n = 28). In chemotaxis assays, sorted granulocytic and monocytic MDSC were tested in response to recombinant IL8, IL8 derived from cancer cell lines, and patient sera. Neutrophil extracellular traps (NETs) formation was assessed by confocal microscopy, fluorimetry, and time-lapse fluorescence confocal microscopy on short-term MDSC cultures. Results: IL8 chemoattracts both granulocytic (GrMDSC) and monocytic (MoMDSC) human MDSC. Monocytic but not granulocytic MDSC exerted a suppressor activity on the proliferation of autologous T cells isolated from the circulation of cancer patients. IL8 did not modify the T-cell suppressor activity of human MDSC. However, IL8 induced the formation of NETs in the GrMDSC subset. Conclusions: IL8 derived from tumors contributes to the chemotactic recruitment of MDSC and to their functional control. Clin Cancer Res; 22(15); 3924–36. ©2016 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cytokines could enhance migration of macrophages and MDSCs to the liver [64, 65] (Fig. 2).”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [65]
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,163
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood
Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., Patel, K. D., Chakrabarti, S., McAvoy, E., Sinclair, G. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1565 · Cited by 2,309
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Urban, C. F., Ermert, D., Schmid, M., Abed, U. A., Goosmann, C., Nacken, W. K. F., Brinkmann, V., Jungblut, P. R., & Zychlinsky, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000639 · Cited by 1,720
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Cited by
Sorted by citations
Items 301–400 of 417
Venous and arterial thrombosis in patients receiving immune checkpoint inhibitors
van Lent, A., Puscasu, R., Kaasjager, K. A. H., Haitjema, S., Suelmann, B. B. M., Verhaar, M. C., Khairoun, M., & Ocak, G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321112 · Cited by 9
Novel insights into immune cells modulation of tumor resistance
Zhou, Y., Na, C., & Li, Z. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104457 · Cited by 9
Ackermann, A., Lafferton, B., Plotz, G., Zeuzem, S., & Brieger, A. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5026 · Cited by 9
“These so‐called myeloid‐derived suppressor cells (MDSCs) can invade rapidly in tumour tissues which is induced by IL‐8 (49,50).”
BackgroundFong, Z., & Lee, W.-L. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0332 · Cited by 9
Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells
Masmoudi, D., Vialaret, J., Hirtz, C., & Alix‐Panabières, C. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13665 · Cited by 8
“Indirectly, IL-8 produced by cancer cells chemotactically attracts MDSCs and induces NET formation by MDSCs [72].”
He, J., Zhou, Z., Cheng, G., Li, H., Tu, J., Fan, Z., Qiu, X., Chen, W., Chen, Y., Li, L., et al. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01789-4 · Cited by 8
“In return, tumor-produced chemokines such as CXCL [10–15] and IL-8 [16, 17] can trigger the creation of NETs.”
Mechanisms and measures to modulate T cell trafficking for amplified and tolerogenic immunity
Lu, Y., Liu, X., & You, J. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102129 · Cited by 8
Human innate immune cell crosstalk induces melanoma cell senescence
Funck, F., Pahl, J. H. W., Kyjacová, L., Freund, L., Oehrl, S., Gräbe, G., Pezer, S., Hassel, J. C., Sleeman, J. P., Cerwenka, A., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1808424 · Cited by 9
Cao, X., Lan, Q., Xu, H., Liu, W., Cheng, H., Hu, X., He, J., Yang, Q., Lai, W., & Chu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113500 · Cited by 8
Li, C., Xue, Y., Yinwang, E., & Ye, Z. (2025) · Cancer Reports · doi:10.1002/cnr2.70044 · Cited by 7
Anoikis and NETosis in colorectal cancer liver metastasis: the relationship and perspectives
Zhang, R., Tan, Y., Jiang, D., Kong, D., Liu, M., Liang, J., Wu, A., & Wang, L. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189401 · Cited by 8
Anchan, M. M., & Dutta, R. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70179 · Cited by 7
“First, it recruits neutrophils and perhaps myeloid-derived suppressor cells (MDSCs) to the tumor site and causes NETosis [71].”
Jia, W., Zhang, J., Shang, Y., & Liu, S. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218103 · Cited by 7
Zhao, Y., Wang, X., Lei, T. B., Lu, H., Zhao, Y., & Wang, G. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004009 · Cited by 7
“[126,127] This signaling axis induces the formation of neutrophil extracellular traps by granulocytic MDSCs, facilitating thrombosis and metastatic dissemination.”
Munansangu, B. S. M., Kenyon, C. P., Walzl, G., Loxton, A. G., Kotzé, L. A., & du Plessis, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073512 · Cited by 7
“reduction of these AA leads to the inhibition of T-cell activation and proliferation and reduced expression of T-cell receptor TCR-CD3 ζ chain, inducing the cell to undergo proliferative arrest [40–42]; (ii) The production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) by MDSC skews the polarizat…”
BackgroundImaging and Therapy of Tumors Based on Neutrophil Extracellular Traps
Hao, Y., Liu, D., Wang, K., Liu, Q., Chen, H., Ji, S., & Ding, D. (2024) · Small Science · doi:10.1002/smsc.202400212 · Cited by 6
The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis
Calderon-Espinosa, E., Ridder, K. D., Benoot, T., Jansen, Y. J. L., Vanhonacker, D., Heestermans, R., Becker, A. D., Riet, I. V., Decoster, L., & Goyvaerts, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397469 · Cited by 6
Pathobiology and clinical significance of malignant pleural effusions
Woods, A. T., Murray, A. A., Vincent, B. G., Akulian, J., & Pecot, C. V. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00363-8 · Cited by 7
Tian, X., Na, J., Tan, X., Dang, F., Zhu, R., Zhong, L., & Zhao, Y. (2026) · Current Oncology · doi:10.3390/curroncol33030156 · Cited by 6
RAGOT, H., Gaucher, S., Claustres, M. B. D., Basset, J., Boudan, R., Battistella, M., Bourrat, E., Hovnanian, A., & Titeux, M. (2024) · Cancers · doi:10.3390/cancers16132476 · Cited by 7
“…, IL-8, and PAD4 associated with an enhanced expression of GM-CSF and/or G-CSF in high-risk pSCCs. IL-1 β has been shown to drive NET formation through IL-8 or G-CSF production in inflammatory diseases including cancers [41,42,44], but also to directly target epithelial–mesenchymal transition [73].”
BackgroundPesini, C., Artal, L., Bernal, J. P., Sánchez‐Martínez, D., Pardo, J., & Ramírez-Labrada, A. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2379062 · Cited by 6
Makatsariya, A. D., Викторовна, С. Е., Bitsadze, V. O., Солопова, А. Г., Khizroeva, J. K., Ashrafyan, L. А., Serov, V. N., Voynovskiy, A. Е., Ungiadze, J. Y., Владимировна, Л. А., et al. (2024) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2024.542 · Cited by 6
Zou, X.-L., Chen, W.-Y., Zhang, G., Ke, H., Yang, Q., & Li, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.747075 · Cited by 6
“IL-8 released by tumors and other cells in the tumor microenvironment is closely related to the accumulation of MDSCs in the tumor (Alfaro et al., 2016).”
BackgroundMa, H., Yao, W., Peng, B., Liu, X., Chen, J., Lin, Y., Di, T., Li, P., & He, X. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117421 · Cited by 6
Extracellular Traps – NETosis and METosis
Konsoula, Z. (2019) · Materials and Methods · doi:10.13070/mm.en.9.2714 · Cited by 6
Hu, Q., Zuo, X., Gu, X., Liu, L., Tang, Y., Niu, X., Shi, Y., & Li-ping, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-05435-w · Cited by 7
“Produced by tumor/stromal/immune cells 21 , it promotes tumor proliferation, EMT, angiogenesis, and immunosuppression.”
Zacchi, F., Merler, S., Zampiva, I., Torresan, I., Manduca, S., Piacentini, M., Lorenzi, C., Fantinel, E., Pafumi, S., Inzerilli, N., et al. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf254 · Cited by 5
Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition
Fujimura, T., Muto, Y., & Asano, Y. (2025) · Biomolecules · doi:10.3390/biom15091317 · Cited by 5
“Notably, tumor-derived IL-8 has been shown to induce the formation of neutrophil extra-cellular traps by granulocytic myeloid-derived suppressor cells, thereby contributing to immunosuppression and metastasis [38].”
Wang, X., Huang, H., Zhang, L., Wu, Y., Wen, Y., Weng, X., Chen, Q., & Liu, W. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02994-8 · Cited by 5
Perioperative NETosis and Cancer Progression: Current Evidence and Future Perspectives
Zhang, Q., Zhang, J., Gu, H., Yang, Y., Zhang, H., & Miao, C. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01573-y · Cited by 6
“Alfaro et al. [20] and Nie et al. [21] found that tumor cells induce NETs formation by releasing IL-8.”
Cancer Therapy-Induced Inflammation and Its Consequences
Saito, R. D. F., Rangel, M. C., Chandler, M. R., Beasock, D., Afonin, K. A., & Chammas, R. J. (2023) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-19-8342-9_4 · Cited by 5
Zhao, N., Jiang, A., Shang, X., Zhao, F., Wang, R., Fu, X., Ruan, Z., Liang, X., Tian, T., Yao, Y., et al. (2023) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000478 · Cited by 5
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
Shibata, Y., Kishida, T., Kouro, T., Wei, F., Igarashi, Y., Himuro, H., Noguchi, T., Koizumi, M., Suzuki, T., Osaka, K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269935 · Cited by 5
Akamatsu, H., Koh, Y., Nishio, M., Goto, Y., Hayashi, H., Miura, S., Tamada, K., Kagamu, H., Gemma, A., Yoshino, I., et al. (2024) · Lung Cancer · doi:10.1016/j.lungcan.2024.108017 · Cited by 4
Next generation CAR-T cells to tackle solid tumors
Abreu, T. R., Godinho‐Santos, A., Amaral, A. T., Paiva, A. A., Moreira, J. N., & Gonçalves, J. R. M. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114650 · Cited by 5
Wang, J., Wang, C., Sun, Z., Zhang, A., Niu, Z., Zhang, K., Wang, S., Zhang, C., Shi, X., Dong, Y., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14698-5 · Cited by 3
“It binds to receptors CXCR1 and CXCR2, driving angiogenesis, immune cell infiltration, and tumor progression in cancers like glioblastoma [14].”
Roles of neutrophil extracellular traps in cancer immunotherapy resistance and therapeutic targeting
Li, X., Shan, D., Zhou, L., Zuo, C., Zheng, L., Li, J., & Yan, M. (2026) · Biomarker Research · doi:10.1186/s40364-026-00949-5 · Cited by 3
“They secrete chemokines, predominantly CXCL1 and IL-8 (CXCL8), which bind to CXCR2 receptors on circulating polymorphonuclear cells [176].”
[Research progress on neutrophil extracellular traps in tumor].
Xu, Y., & Ying, K. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.02.11 · Cited by 3
Sára, B., Kovács, R., Molnár, T., Tóth, M., Szendi-Szatmári, T., Jenei, V., Bíró-Debreceni, Z., Brisco, S., Balázs, M., Bácsi, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274056 · Cited by 3
“This chemokine attracts myeloidderived suppressor cells (MDSC) and activates granulocytic MDSC to extrude DNA-forming neutrophil extracellular traps (NET) [57].”
BackgroundNETs: an extracellular DNA network structure with implication for cardiovascular disease and cancer
Chen, J., Xu, Y., Yu, F., Ma, Z., Yu, J., & Zhang, X. (2024) · Hypertension Research · doi:10.1038/s41440-023-01574-7 · Cited by 5
Tong, L., Kremer, V., Neo, S., Seitz, C., Tobin, N. P., Seliger, B., Harmenberg, U., Colón, E., Scherman-Plogell, A.-H., Liu, L. L., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2481109 · Cited by 3
“19,39,42,43 Najjar et al observed a correlation between the infiltration of the PMN-MDSCs in RCC with the expression of IL-1β, CXCL8, CXCL5, and MIP-1α.”
Kim, G. T., Shin, S., Kim, E. Y., Lee, H., Lee, S. H., Sohn, K., & Kim, J. W. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.051 · Cited by 3
Targeting tumor-associated neutrophils: A promising strategy in lung cancer immunotherapy
Wang, Y., Li, W., Wang, Z., Guo, Y., Zhang, X., & Wan, B. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.02.004 · Cited by 3
“100,101 However, inhibiting CXCR1/2 signaling pathways decreases neutrophil recruitment and in fi ltration, thus preventing CXCR1/2 agonist-induced NETs production, while enhancing T and NK cell to increase anti-tumor immune responses.”
Platelet PI3Kβ regulates breast cancer metastasisPreprint
Graff, R. C., Haimowitz, A., Aguilan, J. T., Levine, A., Zhang, J., Yuan, W., Roose‐Girma, M., Seshagiri, S., Porcelli, S. A., Gamble, M. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.10.612261 · Cited by 3
“IL-8 also plays an important role in the recruitment of neutrophils and myeloid-derived suppressor cells to primary tumors [53].”
BackgroundNazari, P. M. S., Özer, Ö., Roetzer-Pejrimovsky, T., Mair, M. J., Riedl, J., Brostjan, C., Berghoff, A. S., Preusser, M., Hainfellner, J. A., Marosi, C., et al. (2025) · Cancers · doi:10.3390/cancers17193141 · Cited by 2
“Different stimuli (e.g., bacterial pathogens, cytokines, activated platelets, cancer cells) can lead to NETosis of neutrophils, which causes the release of so-called neutrophil extracellular traps (NETs) [22,27–31].”
Khorramdelazad, H., Pirsadeghi, A., Amraei, E., Amani, A., Abbasnia, M., Nematzade, F., Shahabinejad, E., Mahabadi, R. N., Ghanizadeh, S., Kouchakzade, F. S., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118953 · Cited by 3
Soares, J., Ferreira, D., Miranda, A., Gonçalves, M., Relvas‐Santos, M., Brandão, A., Paulo, P., Cotton, S., Freitas, R., Magalhães, M., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02672-y · Cited by 4
“These changes suggest that aberrantly glycosylated CD276 not only impairs T cell activation but also actively recondi-tions the tumor microenvironment to favour immune evasion [51, 52, 81, 82].”
Stojanović, B., Stojanović, B., Stojanovic, M. D., Cvetković, A., Milošević, B., Vulovic, V., Bevc, I. M., Jevtović, A., Tasić-Uroš, D., Knezevic, S., et al. (2026) · Cells · doi:10.3390/cells15060536 · Cited by 2
“Additionally, IL-8-responsive myeloid-derived suppressor cells (MDSCs) that express CXCR1/2 may also participate in the formation of extracellular DNA scaffolds, further broadening the range of cellular contributors to NET-like structures in CRC [193].”
Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics
Huang, S., Ou, Y., Zhuang, W., Huang, J., Wang, B., Li, Z., & Huang, H. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189586 · Cited by 2
Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors
Navin, I., & Parihar, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822620-9.00011-2 · Cited by 2
Laurino, S., Russi, S., Omer, L. C., D’Angelo, A., Bozza, G., Gallucci, G., Falco, G., Roviello, G., & Bochicchio, A. M. (2024) · Diseases · doi:10.3390/diseases12030047 · Cited by 2
“NETs provide Diseases 2024 , 12 , 47 6 of 9 a scaffold for platelets, red blood cells, and pro-coagulant molecules [42–45].”
BackgroundDendooven, A., Esnault, S. J., Jacob, M., Trauet, J., Delaunay, E., Guerrier, T., Samarasinghe, A. E., Mirgot, F., Vuotto, F., Faure, K., et al. (2025) · Cells · doi:10.3390/cells14141093 · Cited by 2
“However, an elevated neutrophils count occurred following a slight augmentation of blood IL-8, a key chemokine for neutrophils, which is associated with the recruitment of immunosuppressive cells [29] and NETosis-prone neutrophils.”
Grützner, E. M., Neizert, A., Stirner, R., Conca, R., Andrä, I., Wolff, L. S., Schiemann, M., Holdt, L. M., Klein, C., Bogner, J. R., et al. (2020) · Translational Medicine Communications · doi:10.1186/s41231-019-0052-5 · Cited by 2
Angiodrastic Chemokines Production by Colonic Cancer Cell Lines
Emmanouil, G., Andrew, M., Tzardi, M., Voumvouraki, A., & Kouroumalis, E. (2022) · Onco · doi:10.3390/onco2020006 · Cited by 2
“MoMDSC were also attracted by CXCL8-containing culture supernatants of HT-29 colon carcinoma cells and by CXCL8-containing sera of patients [43].”
BackgroundDicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway
Han, X., Wu, J., Sha, Z., Lai, R., Shi, J., Mi, L., Yin, F., & Guo, Z. (2023) · Clinical Medicine Insights Oncology · doi:10.1177/11795549231161212 · Cited by 2
Biomarqueurs inflammatoires et immunologiques de réponse à la radiothérapie
Nesseler, J. P., Schaue, D., McBride, W. H., & Nickers, P. (2018) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2017.09.007 · Cited by 2
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
Beck, J. D., Birtel, M., Haefner, E. S., Keil, I. S., Reidenbach, D., Salomon, N., Yildiz, I., & Diken, M. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1675459 · Cited by 2
Huang, W., Xu, Y., Liu, J., Cheng, T., & Tang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-10413-3 · Cited by 1
Li, X., Wang, H., Li, J., Li, C., Zhao, S., Wang, Q., & Ren, W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1593510 · Cited by 2
Mina, A. A., Calvo, K. R., McKinnon, K. M., Raman, A. T., Wang, W., Cunningham, L., Liu, Y., Alexander, R., Larson, D. R., Pavletic, S. Z., et al. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2661078 · Cited by 1
“Interleukin-8 (IL-8, CXCL8 ) is a proinflammatory chemokine and potent chemoattractant of granulocytes, myeloid derived suppressor cells (MDSC), and other inflammatory modulators [4,5].”
Quintás‐Cardama, A., Sanmartín, E., Garcia-Gimenez, A., Muñoz-Langa, J., Collado, A., Suárez, C., del Muro, X. G., Méndez-Vidal, M. J., García-Sánchez, J., Coloma, C. S., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1639330 · Cited by 1
“Moreover, high levels of citrulline have been associated with immunosuppression by enhancing the proliferation of MDSCs in cancer patients.”
InfluentialCai, Y., Su, B., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1743841 · Cited by 1
“In addition, tumor cells have been found to secrete IL-8, attract myeloid-derived suppressor cells, and activate neutrophil precursors to release NETs (72).”
Sobu, R., Kobayashi, Y., Kashima, S., Inoue, T., Sumiyoshi, T., Hamana, H., Takeda, M., Hiroshima, Y., Seki, S., Fujiyama, N., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116386 · Cited by 1
“In comparison to these T-cell-related findings with modest effect sizes, the frequency of M-MDSCs in peripheral blood cells remained consistently higher in NR at all time points.”
InfluentialBenedetto, C. D., Tsark, A., Acenas, D. D., Thach, A., Singhal, A., Opazo-Mellado, V., Rodriguez-Lemus, A., Zeini, M. E., Zhang, H., Park, C., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06456-y · Cited by 1
Targeting tumor microenvironment-associated cells to reverse therapy resistance
Piranlioglu, R., Bradford, J. W., & Arbab, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822527-1.00006-x · Cited by 1
Neutrophil extracellular traps and cancer immune-escape
Pinci, B., Manzanal, A., Gomis, G., Molero-Glez, P., & Teijeira, Á. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00043-6 · Cited by 1
A Positive Feedback DNA-PK/MYT1L-CXCR1-ERK1/2 Proliferative Signaling Loop in Glioblastoma
Wang, B., Li, D., Ilnytskyy, Y., Khachigian, L. M., Zhong, N., Rodriguez‐Juarez, R., Kovalchuk, I., & Kovalchuk, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094398 · Cited by 1
“The tumor-produced IL-8 is a potent chemoattractant that recruits CXCR1/2-expressing human myeloid-derived suppressor cells to tumor foci, playing a crucial role in immune resistance [63].”
Progress in the mechanistic understanding of NETs formation in cancer
Luo, C., Xie, X., Fang, C., Yu, B., Qian, X., Hong, W., Hong, S., Li, H., Wang, Y., & Li, Y. (2025) · Medical Oncology · doi:10.1007/s12032-025-03010-x · Cited by 1
“In 2016, Carlos et al. reported that IL-8 promotes neutrophil DNA extrusion in human colorectal cancer models, facilitating cancer cell proliferation and metastasis [45].”
Liu, Y., & Chen, L. (2025) · Science Progress · doi:10.1177/00368504251374929 · Cited by 1
“24 C-X-C motif chemokine receptor 2 (CXCR2), a chemokine receptor predominantly expressed on leukocytes, plays a pivotal role in the pathogenesis of various in fl ammatory conditions.”
Esmaeilzadeh, A., Jafari, D., Ghaebi, M., Elahi, R., Afshari, F., & Karimi, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-00767-4_202 · Cited by 1
DOW, S. W., & Guth, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-59496-7.00014-1 · Cited by 1
Tang, X. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.53.008349 · Cited by 1
Liu, Z., Wu, X. N., Tian, Y., zhang, W., qiao, S., Xu, W., liu, Y., & Wang, S. (2020) · doi:10.21203/rs.3.rs-21028/v1 · Cited by 1
La’ah, A. S., Tsai, P., Yarmishyn, A. A., Ching, L., Chien, Y., Chen, J. C., Tsai, M., Chen, Y., Ma, C., Hsu, P., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3646385/v1 · Cited by 1
Владимировна, К. Е., Sholokhov, L. F., & Belokrinitskaya, T. E. (2019) · International Conference on Health and Wellbeing in Modern Society (ICHW) · doi:10.2991/ichw-19.2019.33
Neonatal granulocytic MDSCs possess phagocytic properties during bacterial infectionPreprint
Seman, B. G., Vance, J. K., Witt, M. R., & Robinson, C. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.30.891077
“These results are novel, as only one prior study shows that granulocytic MDSCs produce extracellular DNA (Alfaro et al., 2016).”
ResultYuzeir, S., & Gercheva, L. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93651
“Also, cytokine IL-8, which is frequently expressed by different tumour cells, is described as a NET-inducing factor and has recently been proven to be essential for tumour-induced NETosis [31].”
BackgroundVenous thromboembolic complications in lymphoma patients
Otašević, V., Antic, D. A., & Mihaljević, B. (2020) · Medicinski podmladak · doi:10.5937/mp71-29196
“Prilikom formiranja tromba, neutrofili su prvi leukociti koji dolaze na mesto povrede krvnog suda, odmah nakon TF. Stimulacija neutrofila različitim faktorima, uključujući aktivirane endotelne ćelije, IL-8, TNF-α i granulocitni faktor rasta (G-CSF), na kraju može da indukuje razvoj NET, u kojeg se poput mreže hvataju…”
InfluentialPervushin, V. N. (1984) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Lee, P.-H., Yang, T., Chen, K., Huang, Y.-H., Tseng, J., Hsu, K.-H., Wu, Y., Liu, K., & Chang, G. (2021) · Research Square · doi:10.21203/rs.3.rs-145181/v1
DeLeo, F. R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734831746.793580547
Disección mecanística del fracaso loco-regional en cáncer de mama
de Córdoba, B. R. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/63818
Wang, X., Huang, H., Zhang, L., Wu, Y., Weng, X., Chen, Q., Tian, B., Zhang, M., Fu, L., & Liu, W. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4162714
Yan, M., Yao, J., Lin, Y., Yan, J., Xie, Y., Zhou, Y., Wei, J., & Li, X. (2022) · Research Square · doi:10.21203/rs.3.rs-2282569/v1
Esmaeilzadeh, A., Jafari, D., Ghaebi, M., Elahi, R., Afshari, F., & Karimi, L. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_202-1
Data from A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β
Olivera, I., Pamplona, R. S., Bolaños, E., Rodríguez, I., Etxeberría, I., Cirella, A., Egea, J., Garasa, S., Miguéliz, I., Eguren‐Santamaría, I., et al. (2023) · doi:10.1158/2159-8290.c.6549661
Self-citationPineda, A. L. M., Maria, C., Fernando, L.-S., Alma, C., Manuel, G.-M., Martin, A.-B., Juan, M., & Soto-Guzmán, A. (2023) · Medical Research Archives · doi:10.18103/mra.v11i8.4198
Wu, X., Ye, Z., Li, L., Zhang, H., Huang, X., Chai, J., & Zhang, X. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00123
Belluomini, L., Incani, U. C., Smimmo, A., Avancini, A., Sposito, M., Insolda, J., Scaglione, I. M., Gattazzo, F., Caligola, S., Adamo, A., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4846526
唐, 任. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123480
Larkin, R. M., Lopez, D. C., Robbins, Y. L., Lassoued, W., Canubas, K., Warner, A., Karim, B., Vulikh, K., Hodge, J. W., Floudas, C. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26728150
Larkin, R. M., Lopez, D. C., Robbins, Y. L., Lassoued, W., Canubas, K., Warner, A., Karim, B., Vulikh, K., Hodge, J. W., Floudas, C. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25951855
Larkin, R. M., Lopez, D. C., Robbins, Y. L., Lassoued, W., Canubas, K., Warner, A., Karim, B., Vulikh, K., Hodge, J. W., Floudas, C. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25951926
Larkin, R. M., Lopez, D. C., Robbins, Y. L., Lassoued, W., Canubas, K., Warner, A., Karim, B., Vulikh, K., Hodge, J. W., Floudas, C. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26728153
Yan, M., Yao, J., Lin, Y., Yan, J., Xie, Y., Fu, Z., Zhou, Y., Wei, J., & Li, X. (2024) · Figshare · doi:10.6084/m9.figshare.26575712
Comanzo, C. G., Fagalde, F. B., Vera, M. C., Bustos, L. O., Palma, N. F., Capiglioni, A. M., Hesse, L. D., Pisani, G. B., Ferretti, A. C., Ceballos, M. P., et al. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.104301
Habič, A., Milavec, T. K., Žižek, P., Kladnik, Š., Majc, B., Senjor, E., Nanut, M. P., Porčnik, A., Prestor, B., Švajger, U., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02826-y
“Similarly, MDSCs can also be recruited by IL-8 [56, 57] and their accumulation and immune inhibitory functions are enhanced by IL-6 [58].”
Champiat, S. (2019) · theses.fr (ABES) · doi:10.70675/e358773dz1898z4feezbb3bzbdee7c7f20a6
Metadata
- Authors
- Alfaro, C., Teijeira, A., Oñate, C., Pérez, G., Sanmamed, M. F., Andueza, M. P., Alignani, D., Labiano, S., Azpilikueta, A., Rodriguez-Paulete, A., Garasa, S., Fusco, J. P., Aznar, A., Inogés, S., De Pizzol, M., Allegretti, M., Medina-Echeverz, J., Berraondo, P., Perez-Gracia, J. L., & Melero, I.
- Affiliations
- Clinica Universidad de Navarra (ES)
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
- Centro de Investigación Médica Aplicada (ES)
- 5Dompé Farmaceutici SpA, L'Aquila, Italy.
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2016-07-31
- Volume
- 22
- Issue
- 15
- Pages
- 3924-3936
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2298626553
- Cited by
- 417
- References
- 53
- Citations by year
- 2026: 35 · 2025: 33 · 2024: 44 · 2023: 54 · 2022: 54 · 2021: 59 · 2020: 46 · 2019: 35 · 2018: 22 · 2017: 21 · 2016: 13
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- interleukin-8, myeloid-derived suppressor cells, neutrophil extracellular traps, tumor microenvironment, chemotaxis, granulocytic MDSCs, monocytic MDSCs, T cell suppression, tumor immunosuppression, tumor-derived cytokines
- MeSH terms
- Myeloid-Derived Suppressor Cells, Animals, Chemotaxis, Leukocyte, Disease Models, Animal, Humans, Neoplasms, Neutrophils, Sulfonamides, Biomarkers, T-Lymphocyte Subsets, Interleukin-8, Mice, Knockout, Cell Line, Tumor, Mice, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review